AIMT

Aimmune Therapeutics, Inc.
AIMT

Delisted

AIMT was delisted on the 12th of October, 2020.

165 hedge funds and large institutions have $824M invested in Aimmune Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 72 increasing their positions, 37 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+4
Holders Change %
+2.48%
% of All Funds
3.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
26
Increased
72
Reduced
37
Closed
22
Calls
$8.67M
Puts
$5.11M
Net Calls
+$3.55M
Net Calls Change
+$2.3M
Name Holding Trade Value Shares
Change
Shares
Change %
FPS
176
Fieldpoint Private Securities
Connecticut
-$183K -12,669 Closed
BCM
177
Bayesian Capital Management
New York
-$168K -11,621 Closed
Group One Trading
178
Group One Trading
Illinois
-$153K -10,617 Closed
LCS
179
Levin Capital Strategies
New York
-$144K -10,000 Closed
AT
180
Arden Trust
Delaware
-$113K -7,831 Closed
Walleye Trading
181
Walleye Trading
New York
-$104K -7,240 Closed
AAMU
182
Amundi Asset Management US
Massachusetts
-$92K -6,400 Closed
JSC
183
Jackson Square Capital
California
-$35K -2,394 Closed
Simplex Trading
184
Simplex Trading
Illinois
-$2K -200 Closed
Northwestern Mutual Wealth Management
185
Northwestern Mutual Wealth Management
Wisconsin
-$1K -76 Closed